Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.072 AUD | -4.00% | +26.32% | +227.27% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+227.27% | 8.5M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.89% | 248B | |
-1.60% | 219B | |
+11.25% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Opts to Advance NYR-BI03 Brain Injury Drug Candidate